Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 2Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Liver Neoplasms 1Liver Cirrhosis 1Leiomyoma 1Inflammation 1Frailty 1Carcinoma, Hepatocellular 1Atypical Squamous Cells of the Cervix 1

Interventions

Conization 3Papillomavirus Vaccines 2Human Papillomavirus DNA Tests 2Colposcopy 2pembrolizumab 1epigallocatechin gallate 1artesunic acid 1artemisinin 1Watchful Waiting 1Transurethral Resection of Prostate 1Restraint, Physical 1Pregnancy Tests 1Liquid Biopsy 1Imiquimod 1Hysterectomy 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Fenofibrate 1Chemoradiotherapy 1Blood Specimen Collection 1Biopsy 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Uterine Cervical Dysplasia × epigallocatechin gallate × Clear all
NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡